Research Topics
Species | Eugene R SchiffSummaryAffiliation: University of Miami Country: USA Publications
| Collaborators
|
Detail Information
Publications
Diagnosing and treating hepatitis C virus infectionEugene R Schiff
Schiff Liver Institute Center for Liver Diseases, University of Miami Miller School of Medicine, 1500 NW 12 Ave, Jackson Medical Tower E 1101, Miami, FL 33136, USA
Am J Manag Care 17:S108-15. 2011..Several new therapies for HCV infection are in development. Protease inhibitors are expected to become the new standard of care for nonresponders, with the potential to become a first-line treatment for chronic HCV infection...- Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersEugene R Schiff
Division of Hepatology, University of Miami, Jackson Medical Towers, 1500 N W 12th Avenue, Suite 1101, Miami, FL 33136, USA
J Hepatol 38:818-26. 2003..We assessed lamivudine treatment, with or without added interferon, in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B who had failed interferon therapy previously... - IntroductionEugene R Schiff
Division of Hepatology, University of Miami School of Medicine, Miami, Florida 33136, USA
Am J Med 118:1S-6S. 2005 - Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patientsEugene R Schiff
Center for Liver Diseases, University of Miami, Miami, FL 33136, USA
Hepatology 38:1419-27. 2003..In conclusion, 48 weeks of adefovir dipivoxil resulted in significant improvements in virologic, biochemical, and clinical parameters in CHB patients pre- and post-LT with lamivudine-resistant HBV... - Prevention of mortality from hepatitis B and hepatitis CEugene R Schiff
Division of Hepatology, Center for Liver Disease, University of Miami School of Medicine, Miami, FL 33136, USA
Lancet 368:896-7. 2006 - Emerging strategies for pegylated interferon combination therapyEugene R Schiff
University of Miami School of Medicine, 1500 NW 12 Avenue, Jackson Medical Tower E 1101, Miami, FL 33136, USA
Nat Clin Pract Gastroenterol Hepatol 4:S17-21. 2007..Challenges include the prevention of recurrent HCV infection in liver-transplant recipients and development of a safe and effective HCV vaccine... - Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term resultsEugene Schiff
Center for Liver Diseases, University of Miami, Miami, FL 33136, USA
Liver Transpl 13:349-60. 2007..In conclusion, adefovir dipivoxil is effective and safe in wait-listed or posttransplantation CHB patients with lamivudine-resistant HBV and prevents graft reinfection with or without HBIg... 
Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis BEugene R Schiff
University of Miami Hospital and Clinics, Miami, Florida, USA
Clin Gastroenterol Hepatol 9:274-6. 2011..Patients with advanced fibrosis or cirrhosis, who received long-term entecavir treatment, were evaluated for improvement in liver histology...- Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaGuy W Neff
Center for Liver Diseases and Division of GI Transplant, Department of Medicine, University of Miami, FL 33136, USA
Liver Transpl 10:595-8. 2004..In conclusion, direct detection of HCV RNA by RT-PCR of liver tissue appears to more effectively predict SVR following pegylated interferon and ribavirin therapy than the conventional use of serum... - Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapyGuy W Neff
Center for Liver Diseases, Division of GI Transplant, Department of Medicine, University of Miami, Miami, FL, USA
Transplantation 78:1303-7. 2004..We present data from a retrospective review in liver-transplant recipients suffering from HCV recurrence that were treated with pegylated alpha-2b interferon and ribavirin... - Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decadeGuy W Neff
Center for Liver Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
Liver Transpl 10:1372-8. 2004..In conclusion, pre-LTx HBV viremia should be considered in planning post-LTx prophylaxis. Trials to evaluate oral antiviral agents in combination with or without HBIg therapy are needed... - Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infectionHideo Yoshida
Division of Liver GI Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, FL 33136, USA
Clin Transplant 21:166-71. 2007..Background: The aim of this study was to evaluate the efficacy of lamivudine (LAM) monoprophylaxis for patients with non-replicating hepatitis B virus (HBV) infection at orthotopic liver transplantation (OLT)... - Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver diseaseVishal Bhagat
Center for Liver Diseases, University of Miami Leonard M Miller School of Medicine, Miami, FL, USA
Liver Transpl 15:1814-20. 2009..Acute rejection and recurrent steatohepatitis were significantly more frequent in the NASH group but did not lead to higher rates of retransplantation... - Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantationArie Regev
Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, Miami, FL 33136, USA
Liver Transpl 10:1233-9. 2004..Histopathologic assessment should be used cautiously for the differentiation of RHC from ACR post-LT... 
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesIan R Schreibman
Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M Miller School of Medicine, Miami, FL, USA
Ann Clin Microbiol Antimicrob 5:8. 2006..Particular attention will be paid to the newer nucleoside and nucleotide analogs and the direction for future strategies to treat HBV in the post transplant setting...- Outcomes after orthotopic liver transplantation in 15 HIV-infected patientsIan Schreibman
Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M Miller School of Medicine, Miami, FL 33136, USA
Transplantation 84:697-705. 2007..Highly active antiretroviral therapy (HAART) has led to an increasing number of successful OLTs. The aim of this study was to examine survival and cause-specific mortality in HIV-infected patients after OLT at our institution... - Pretreatment laparoscopic appearance of the liver can predict response to combination therapy with interferon alpha 2B and ribavirin in chronic hepatitis CJasmohan S Bajaj
Center for Liver Diseases, University of Miami School of Medicine, Miami, Florida 33136, USA
Gastrointest Endosc 58:380-3. 2003..Laparoscopy and biopsy are complementary for the diagnosis of cirrhosis in hepatitis C... - Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virusVishal Bhagat
Center for Liver Diseases, Division of Hepatology, Leonard M Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Liver Transpl 14:92-5. 2008..Spontaneous clearance of chronic HCV infection can occur in HIV-HCV-coinfected patients after liver transplantation. The mechanism of this phenomenon remains unclear... - Imatinib mesylate (gleevec) hepatotoxicityAyse L Mindikoglu
Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M Miller School of Medicine, Miami, FL 33136, USA
Dig Dis Sci 52:598-601. 2007 - Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinomaNoriyo Yamashiki
Division of Transplantation, Department of Surgery, University of Miami School of Medicine, Miami, FL, USA
Am J Transplant 4:774-81. 2004..001). In conclusion, the initial AFP level may be useful along with tumor stage in defining an urgency score for liver transplant candidates with HCC... - Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control studyArie Regev
Division of Hepatology, Center for Liver Diseases, University of Miami, Leonard M Miller School of Medicine, FL 33136, USA
J Pediatr Gastroenterol Nutr 43:S30-5. 2006..The role of the heterozygous PiZ state of alpha-1 antitrypsin deficiency (alpha1ATD) in the pathogenesis of chronic liver disease (LD) is still a matter of controversy... - Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantationLuis Servin-Abad
Division of Hepatology, Center for Liver Diseases, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
Liver Transpl 12:1161-5. 2006..A third OLT led again to disappearance of the clinical and radiological manifestations of AHD. AHD may show complete resolution after OLT; however it may rapidly recur following recurrent liver disease or graft dysfunction... - Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its preventionAyse L Mindikoglu
Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA
Clin Gastroenterol Hepatol 4:1076-81. 2006..Prophylactic treatment with a nucleoside or nucleotide analogue should be considered strongly to prevent HBV reactivation in these patients... - Budd-Chiari-like presentation of hepatic adenomaAbhasnee Sobhonslidsuk
Center for Liver Diseases, Department of Medicine, University of Miami School of Medicine, Miami, USA
J Gastroenterol Hepatol 20:653-6. 2005..The lesion compressed the hepatic vein and created an early stage of Budd-Chiari syndrome. Tumor resection was carried out successfully. The final diagnosis of this case was multiple hepatic adenomas... - Alcohol and hepatitis CKamran Safdar
Center for Liver Diseases, Division of Hepatology, Department of Medicine, University of Miami, Miami, Florida 33136, USA
Semin Liver Dis 24:305-15. 2004..Alcohol abuse causes decreased response to interferon treatment in HCV patients. It is therefore necessary for patients with HCV infection to abstain from alcohol consumption... - Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted liversNoriyo Yamashiki
Division of Hepatology, Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA
Am J Gastroenterol 98:2052-9. 2003..Pathologists need to be aware that after this form of therapy, portions of the tumor maintain their native morphological features as if the area is fixed, but their cellular activity is destroyed... - Relapsing polychondritis, chronic hepatitis C virus infection, and mixed cryoglobulemiaIvonne Herrera
Department of Medicine, University of Miami School of Medicine, Miami, FL, USA
Semin Arthritis Rheum 33:388-403. 2004..Treatment with IR improved the symptoms of RP. It is not known whether the effects of IR were directly on the RP or suppressed RP indirectly through the actions on the viral load or active hepatitis... - Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver diseaseGuy W Neff
Department of Medicine, Division of GI Transplant, University of Miami, Miami, FL 33136, USA
Liver Transpl 9:239-47. 2003..Given the complex pharmacologic interactions between the protease inhibitors and tacrolimus, careful monitoring, and attention is required to prevent toxicity or underdosing... - Beneficial effects of topical testosterone replacement in patients with end-stage liver diseaseGuy W Neff
Center for Liver Diseases, Division of GI Transplant, Department of Medicine, University of Miami, Miami, Florida, USA
Dig Dis Sci 49:1186-9. 2004 - Predictors of cirrhosis in Hispanic patients with nonalcoholic steatohepatitisWaleed M Alazmi
Division of Gastroenterology, Center for Liver Diseases, University of Miami Leonard M Miller School of Medicine, Miami, Florida 33136, USA
Dig Dis Sci 51:1725-9. 2006..Age was an independent predictor in both groups, however, AST/ALT ratio was found to be an independent predictor of cirrhosis only in Hispanic patients, and diabetes mellitus only in non-Hispanic patients... - Dilatation of biliary strictures through the afferent limb of a Roux-en-Y choledochojejunostomy in patients with sclerosing cholangitisD G Hutson
Department of Surgery, University of Miami School of Medicine, Florida 33101, USA
World J Surg 25:1251-3. 2001..Six patients are presently alive with an average survival of 159 months. The study suggests that a combination of repeated dilatations combined with transplantation is the approach of choice in selected patients... - Liver disease in the elderlyA Regev
Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, Miami, Florida, USA
Gastroenterol Clin North Am 30:547-63, x-xi. 2001..Although there are no liver diseases specific to advanced age, the presentation, clinical course and management of liver diseases in the elderly may differ in important respects from those of younger individuals... - Focal nodular hyperplasia in identical twinsAyse L Mindikoglu
Center for Liver Diseases, Division of Hepatology, Department of Surgery, University of Miami School of Medicine, Miami, Florida 33136, USA
Am J Gastroenterol 100:1616-9. 2005..This case report strongly supports the theory of a congenital vascular anomaly playing a major role in the etiology of focal nodular hyperplasia... - Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trialLynn G Feun
Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, 1475 NW 12th Avenue, Miami, Florida, USA
J Cancer Res Clin Oncol 129:17-20. 2003..CONCLUSIONS: This chemotherapy combination was generally well tolerated, but has limited activity in unresectable, advanced hepatocellular carcinoma... - Hepatitis C and alcoholEugene R Schiff
Division of Hepatology, University of Miami School of Medicine, Miami, Florida, USA
Alcohol Res Health 27:232-9. 2003..Research areas that have the greatest potential for developing more effective treatment options include HCV virology, immunology, animal models, and the mechanisms of liver injury... - Epithelioid hemangioendothelioma of the liverAyse L Mindikoglu
Center for Liver Diseases, Division of Hepatology, University of Miami School of Medicine, Miami, Florida, USA
Clin Gastroenterol Hepatol 3:xxxii. 2005 - Multiple normal deliveries in a woman with severe portal hypertension due to congenital hepatic fibrosis: the importance of preserved hepatocellular functionAyse L Mindikoglu
Center for Liver Diseases, Division of Hepatology, University of Miami Leonard M. Miller School of Medicine, Miami, Florida 33136, USA
Am J Gastroenterol 100:2359-61. 2005.... - Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionArie Regev
Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, Florida 33136, USA
Am J Gastroenterol 97:2614-8. 2002..A sampling error may have led to underdiagnosis of cirrhosis in 14.5% of the patients. These differences could not be attributed to intraobserver variation, which appeared to be low... - A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejectionGuy W Neff
University of Miami, Department of Medicine, Miami, FL 33136, USA
Liver Transpl 9:477-83. 2003..Recombinant erythropoietin was started in 5 of 21 patients. Sirolimus serum levels were found to be greater than 20 ng/dL in 12 patients. Sirolimus was discontinued in 9 patients,.. - Acetaminophen safety and hepatotoxicity--where do we go from here?Patrick J Amar
University of Miami Miller School of Medicine, Division of Hepatology, Miami, Florida 33136, USA
Expert Opin Drug Saf 6:341-55. 2007..Additionally, expert opinion is presented herein to aid in reducing the frequency and severity of liver injury from acetaminophen... - High frequency of genotype D and spontaneous hepatitis B virus genomic mutations among Haitians in a multiethnic North American populationClaudia A Couto
Department of Internal Medicine and Alfa Gastroenterology Institute, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
J Clin Gastroenterol 47:83-8. 2013..We aimed to determine HBV genotype, precore (PC), and basal core promoter region (BCP) mutations in a HBV multiethnic South Florida population... - Combined central retinal vein and central retinal artery occlusions and neovascular glaucoma associated with interferon treatmentAleksandra V Rachitskaya
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 N W 17th Street, Miami, FL 33136, USA
Eur J Ophthalmol 22:284-7. 2012..Interferon retinopathy is associated with ischemic retinal cotton-wool spots. This case illustrates how IFN can lead to severe and sight-threatening retinal ischemia... - Diagnostic laparoscopy in radiation-induced liver diseaseEduardo B V da Silveira
Division of Hepatology, University of Miami School of Medicine, Miami, Florida, USA
Gastrointest Endosc 55:432-4. 2002 - Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantationS Tamura
Division of Transplantation, Department of Surgery, University of Miami School of Medicine, 1801 NW Ninth Ave, Highland Professional Building, Suite 511, Miami, FL 33136, USA
Arch Surg 136:25-30; discussion 31. 2001..However, before altering the current OLT selection criteria for patients with HCC, prospective studies are required to confirm the impact of histological grade on clinical outcome... - Prediction of survival outcome of ICU patients awaiting orthotopic liver transplantationA Sobhonslidsuk
Center for Liver Diseases, University of Miami, Miami, Florida 33136, USA
Transplant Proc 34:1223-5. 2002 - Effect of pretransplant hepatitis C virus RNA status on posttransplant outcomeC G Nudo
Center for Liver Diseases, Division of Hepatology, University of Miami, Leonard M Miller School of Medicine, Miami, Florida 33136, USA
Transplant Proc 40:1449-55. 2008..8%/75.6% and 89.6%/77.8% for RNA(-) and (+) groups, respectively (P = .77). In conclusion, RNA(-)-transplanted patients displayed lower VR and longer time to HR. The SVR patients showed lower VR and HR compared to ETR and RNA(+) patients... - Nyquil-associated liver injuryR T Foust
University of Miami School of Medicine, Florida
Am J Gastroenterol 84:422-5. 1989..We report two cases of unintentional liver injury associated with ingestion of Nyquil, a liquid cold remedy containing acetaminophen and 25% alcohol... - Drug therapy for hepatitis BA Regev
Division of Hepatology, Center for Liver Diseases, University of Miami School of Medicine, Miami, Fla, USA
Adv Intern Med 46:107-35. 2001..This combination may act synergistically against HBV and delay or prevent the development of drug-resistant mutants... - Large cystic lesions of the liver in adults: a 15-year experience in a tertiary centerA Regev
Department of Internal Medicine, University of Miami School of Medicine, FL, USA
J Am Coll Surg 193:36-45. 2001..Malignant transformation is an uncommon but real risk. Open resection is a safe and effective treatment for hepatobiliary cystadenoma, and is associated with a low recurrence rate... - Sirolimus therapy in orthotopic liver transplant recipients with calcineurin inhibitor related chronic renal insufficiencyG W Neff
University of Miami, Miami, Florida, USA
Transplant Proc 35:3029-31. 2003..CONCLUSION: This retrospective review suggests that OLT patients suffering from tacrolimus-related renal insufficiency successfully converted to sirolimus may benefit from this therapy... - Histological outcome during long-term lamivudine therapyJules L Dienstag
Gastrointestinal Unit Medical Services, Massachusetts General Hospital, Boston, MA 02114, USA
Gastroenterology 124:105-17. 2003..One year of lamivudine for chronic hepatitis B results in histologic improvement. We aimed to assess the histological impact of longer-term treatment... - Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled studyNezam H Afdhal
Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Gastroenterology 126:1302-11. 2004..This study assessed whether epoetin alfa could maintain RBV dose, improve quality of life (QOL), and increase hemoglobin (Hb) in anemic HCV-infected patients... - Chronic hepatitis B: a critical appraisal of current approaches to therapyRobert P Perrillo
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Clin Gastroenterol Hepatol 4:233-48. 2006..Expert opinions may differ from those of practicing hepatologists and gastroenterologists. We aimed to explore this issue further after a critical review of the literature... - Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapyPaul J Pockros
Scripps Clinic, La Jolla, CA 92037, USA
Hepatology 40:1450-8. 2004..Hb improvement was an independent predictor of HRQL improvement in these patients. In conclusion, epoetin alfa provided clinically significant HRQL improvement in HCV-infected patients receiving IFN/RBV therapy... - A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosisHie Won L Hann
Department of Medicine, Jefferson Medical College, 1025 Walnut Street Room 910, Philadelphia, PA 19107, USA
Liver Transpl 9:49-56. 2003..Additional studies of lamivudine in combination with other antivirals are indicated for the large population of patients worldwide with advanced HBV-related cirrhosis and inadequate access to liver transplantation... - Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis BRobert P Perrillo
Section of Gastroenterology and Hepatology, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA
Hepatology 36:186-94. 2002..Asians and Caucasians had similar rates of response to lamivudine at comparable ALT levels... - Long-term safety of lamivudine treatment in patients with chronic hepatitis BAnna S F Lok
Division of Gastroenterology, University of Michigan Medical Center, Ann Arbor, 48109 0362, USA
Gastroenterology 125:1714-22. 2003..The aim of this analysis was to determine the incidence of hepatitis flares, hepatic decompensation, and liver-disease-related (LDR) serious adverse events (SAE) during long-term lamivudine treatment... - A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patientsTing Tsung Chang
National Cheng Kung University Medical College, Tainan, Taiwan
Gastroenterology 129:1198-209. 2005..This randomized, dose-ranging, phase 2 study compared the efficacy and safety of entecavir with lamivudine in lamivudine-refractory patients... - Tenofovir therapy for lamivudine resistance following liver transplantationGuy W Neff
College of Medicine, University of Cincinnati, 231 Albert Sabin Way, MSB Room 6560, Cincinnati, OH 45267 0595, USA
Ann Pharmacother 38:1999-2004. 2004..Resistant hepatitis B virus (HBV) strains develop in 30% of liver transplant recipients treated with lamivudine within 2 years from the time of transplantation... - Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practiceMitchell L Shiffman
Hepatology Section, Virginia Commonwealth University Health System Medical College of Virginia, Richmond, Virginia 23298, USA
Am J Gastroenterol 98:1159-66. 2003..The present study was performed to evaluate the impact of the international unit standard for measuring HCV RNA in the management of patients with chronic hepatitis C virus (HCV) infection... - A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an updateEmmet B Keeffe
Division of Gastroenterology and Hepatology, Stanford University Medical Center, CA 94304, USA
Clin Gastroenterol Hepatol 4:936-62. 2006..Issues for consideration include efficacy, safety, incidence of resistance, method of administration, and cost... - A treatment algorithm for the management of chronic hepatitis B virus infection in the United StatesEmmet B Keeffe
Stanford University Medical Center, 750 Welch Road, Suite 210, Palo Alto, California 94304 1509, USA
Clin Gastroenterol Hepatol 2:87-106. 2004.... - Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis CPaul J Pockros
Division of Gastroenterology and Hepatology, Scripps Clinic, La Jolla, CA 92037, USA
Hepatology 46:324-9. 2007..Longer studies to assess potential effects of IDN-6556 on liver inflammation and fibrosis are merited... - Alcohol consumption by cirrhotic subjects: patterns of use and effects on liver functionMichael R Lucey
Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792 5124, USA
Am J Gastroenterol 103:1698-706. 2008.... - Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survivalTimothy R Morgan
VA Long Beach Healthcare Systems, Long Beach, CA 90822, USA
Gastroenterology 128:882-90. 2005..Colchicine improved survival and reversed cirrhosis in several small clinical trials. We compared the efficacy and safety of long-term colchicine, as compared with placebo, in patients with advanced alcoholic cirrhosis... - Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver diseaseCharles S Lieber
James J Peters Veterans Affairs Medical Center, Bronx, New York 10468, USA
Alcohol Clin Exp Res 32:1031-9. 2008..Moreover, a diagnostic algorithm including 3 serum markers (TIMP1, PIIINP, HA) and age has been proposed to accurately detect fibrosis with acceptable levels of sensitivity/specificity in a chronic hepatitis C subgroup... - Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shuntThomas D Boyer
Department of Medicine, University of Arizona, Liver Research Institute, Tucson, AZ 85724, USA
J Hepatol 48:407-14. 2008..We examined the cost and cost effectiveness of distal splenorenal shunt (DSRS) and transjugular intrahepatic portosystemic shunt (TIPS) in the prevention of variceal rebleeding...